Company Profile

• HIGHLIGHTS - SMILAX MANUFACTURES ACTIVE PHARMA INGREDIENTS (APIS), ADVANCED DRUG INTERMEDIATES AND PELLETS FOR GLOBAL PHARMA COMPANIES - PORTFOLIO COVERS VARIOUS THERAPEUTIC AREAS SUCH AS GASTROINTESTINAL, CARDIOVASCULAR, AND CENTRAL NERVOUS SYSTEM - PRODUCTS ARE SUPPLIED TO HUNDREDS OF CLIENTS ACROSS INDIA, ASIA, LATIN AMERICA, MIDDLE EAST, EUROPE, JAPAN AND OTHER COUNTRIES - OPERATES IN A BUILT UP AREA OF 350,000SFT • ACCOMPLISHMENTS: • SMILAX IS AN APPROVED API SOURCE FOR MANY PRESTIGIOUS CLIENTS, INCLUDING THE TOP FIVE IN THE EU, JAPAN, KOREA AND INDIA • 475KL MULTIPLE BLOCK FACILITY • COST EFFECTIVE MANUFACTURING INFRASTRUCTURE • STATE OF THE ART R&D CENTRE WITH 40 MEMBER TEAM • FACILITIES MEETING CGMP REQUIREMENTS FOR USA, EU • SMILAX IS AUDITED AND APPROVED BY EUROPEAN REGULATORY AGENCY, EMA; BY USFDA; AND RECEIVED THE PMDA ACCREDITATION FROM JAPAN